Special Drug Use Investigation for LAMICTAL (Long Term)

Trial Profile

Special Drug Use Investigation for LAMICTAL (Long Term)

Phase of Trial: Phase IV

Latest Information Update: 11 Nov 2016

At a glance

  • Drugs Lamotrigine (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 08 Nov 2016 Status changed from active, no longer recruiting to completed.
    • 26 Jun 2014 Planned End Date changed from 1 Dec 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.
    • 04 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top